Literature DB >> 18636041

Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis: a comparison of the Pitt bacteremia score and the Acute Physiology and Chronic Health Evaluation II scoring systems.

Ji-Young Rhee1, Ki Tae Kwon, Hyun Kyun Ki, Sang Yop Shin, Dong Sik Jung, Doo-Ryeon Chung, Byoung-Chun Ha, Kyong Ran Peck, Jae-Hoon Song.   

Abstract

This study compares the effectiveness of the Pitt bacteremia score, the Charlson weighted index of comorbidity, and the Acute Physiology and Chronic Health Evaluation II (APACHE II) scoring systems for the prediction of mortality in intensive care unit (ICU) patients with sepsis using the retrospective observational method on 134 patients with ICU-acquired sepsis. The statistical analyses show several important findings. First, Pitt bacteremia score is significantly correlated with the APACHE II scoring system (correlation coefficient = 0.738, P < 0.001). Second, the APACHE II scoring system, the Pitt bacteremia score, and the Charlson weighted index of comorbidity are independently correlated with mortality. Third, the Pitt bacteremia score and the APACHE II scores are positively related to mortality in patients with ICU-acquired sepsis. As the result of the analyses, the mortality rate in patients with sepsis in the ICU is better predicted with the Pitt bacteremia score because it provides better estimation of sensitivity and specificity than the APACHE II scoring system and the Charlson weighted index of comorbidity.

Entities:  

Mesh:

Year:  2009        PMID: 18636041     DOI: 10.1097/SHK.0b013e318182f98f

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  60 in total

1.  Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis.

Authors:  Pilar Retamar; María M Portillo; María Dolores López-Prieto; Fernando Rodríguez-López; Marina de Cueto; María V García; María J Gómez; Alfonso Del Arco; Angel Muñoz; Antonio Sánchez-Porto; Manuel Torres-Tortosa; Andrés Martín-Aspas; Ascensión Arroyo; Carolina García-Figueras; Federico Acosta; Juan E Corzo; Laura León-Ruiz; Trinidad Escobar-Lara; Jesús Rodríguez-Baño
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

2.  Utility and safety of procalcitonin in an antimicrobial stewardship program (ASP) in patients with malignancies.

Authors:  Y X Liew; W Lee; Y Y Cai; J Teo; S S-L Tang; R W-Q Ong; C L-L Lim; P B Lingegowda; A L-H Kwa; M P Chlebicki
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-08       Impact factor: 3.267

3.  An outbreak of Burkholderia cenocepacia bacteremia in immunocompromised oncology patients.

Authors:  T Mann; D Ben-David; A Zlotkin; D Shachar; N Keller; A Toren; A Nagler; G Smollan; A Barzilai; G Rahav
Journal:  Infection       Date:  2010-04-01       Impact factor: 3.553

4.  Empiric weight-based vancomycin in intensive care unit patients with methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Carlos A Alvarez; Christopher A Giuliano; Krystal K Haase; Kathleen A Thompson; Christopher R Frei; Nicolas A Forcade; Sara D Brouse; Eric M Mortensen; Todd Bell; Roger J Bedimo; Nolan M Toups; Ronald G Hall
Journal:  Am J Med Sci       Date:  2014-11       Impact factor: 2.378

5.  Evaluating antibiotic stewardship programs in patients with bacteremia using administrative data: a cohort study.

Authors:  J Boel; M Søgaard; V Andreasen; J O Jarløv; M Arpi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-04-17       Impact factor: 3.267

6.  Complete adherence to evidence-based quality-of-care indicators for Staphylococcus aureus bacteremia resulted in better prognosis.

Authors:  Miki Nagao; Masaki Yamamoto; Yasufumi Matsumura; Isao Yokota; Shunji Takakura; Satoshi Teramukai; Satoshi Ichiyama
Journal:  Infection       Date:  2016-10-05       Impact factor: 3.553

7.  Outcomes in Documented Pseudomonas aeruginosa Bacteremia Treated with Intermittent IV Infusion of Ceftazidime, Meropenem, or Piperacillin-Tazobactam: A Retrospective Study.

Authors:  Francine Kwee; Sandra A N Walker; Marion Elligsen; Lesley Palmay; Andrew Simor; Nick Daneman
Journal:  Can J Hosp Pharm       Date:  2015 Sep-Oct

8.  Derivation of a quick Pitt bacteremia score to predict mortality in patients with Gram-negative bloodstream infection.

Authors:  Sarah E Battle; Matthew R Augustine; Christopher M Watson; P Brandon Bookstaver; Joseph Kohn; William B Owens; Larry M Baddour; Majdi N Al-Hasan
Journal:  Infection       Date:  2019-02-08       Impact factor: 3.553

9.  Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.

Authors:  Pranita D Tamma; Katherine E Goodman; Anthony D Harris; Tsigereda Tekle; Ava Roberts; Abimbola Taiwo; Patricia J Simner
Journal:  Clin Infect Dis       Date:  2016-11-09       Impact factor: 9.079

10.  Sepsis chronically in MARS: systemic cytokine responses are always mixed regardless of the outcome, magnitude, or phase of sepsis.

Authors:  Marcin F Osuchowski; Florin Craciun; Katrin M Weixelbaumer; Elizabeth R Duffy; Daniel G Remick
Journal:  J Immunol       Date:  2012-09-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.